Core Laboratories (NYSE:CLB) Issues Earnings Results

Core Laboratories (NYSE:CLB) posted its quarterly earnings data on Wednesday. The oil and gas company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.03, FiscalAI reports. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%. Core Laboratories updated its Q3 2026 guidance to 0.120-0.200 EPS.

Core Laboratories Stock Performance

Shares of NYSE:CLB traded down $0.82 during midday trading on Wednesday, hitting $9.87. The stock had a trading volume of 1,604,259 shares, compared to its average volume of 590,079. Core Laboratories has a 1 year low of $9.72 and a 1 year high of $20.36. The stock has a 50 day moving average price of $12.24 and a two-hundred day moving average price of $15.38. The company has a market capitalization of $454.75 million, a PE ratio of 15.18, a P/E/G ratio of 2.71 and a beta of 1.00. The company has a current ratio of 2.05, a quick ratio of 1.50 and a debt-to-equity ratio of 0.42.

Hedge Funds Weigh In On Core Laboratories

A number of large investors have recently modified their holdings of the business. Platinum Investment Management Ltd. lifted its holdings in shares of Core Laboratories by 3.9% in the 3rd quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock valued at $294,000 after buying an additional 889 shares during the period. The Manufacturers Life Insurance Company raised its position in Core Laboratories by 6.2% in the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock worth $207,000 after acquiring an additional 1,040 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Core Laboratories by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after acquiring an additional 1,170 shares in the last quarter. Quarry LP lifted its holdings in Core Laboratories by 118.1% in the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after acquiring an additional 1,599 shares during the period. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of Core Laboratories during the 4th quarter worth $34,000. 97.81% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on CLB shares. Wall Street Zen cut shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. Weiss Ratings downgraded shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Reduce”.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.